Glutathione-dependent cell cycle G1 arrest and apoptosis induction in human lung cancer A549 cells caused by methylseleninic acid: Comparison with sodium selenite

Biological and Pharmaceutical Bulletin

Volumn 37, Issue 11, 2014, Pages 1831-1837

  Okuno, Tomofumi ^a   Honda, Eri ^a   Arakawa, Tomohiro ^a   Ogino, Hirofumi ^a   Ueno, Hitoshi ^a  

^a SETSUNAN UNIVERSITY   (Japan)

Author keywords

Apoptosis; Cell cycle arrest; Human lung cancer A549 cell; Methylseleninic acid; Reduced glutathione

Indexed keywords

ANTINEOPLASTIC AGENT; GLUTATHIONE; METHYLSELENINIC ACID; SODIUM SELENITE; UNCLASSIFIED DRUG; METHYLSELENIC ACID; ORGANOSELENIUM DERIVATIVE;

APOPTOSIS; ARTICLE; CELL CYCLE ARREST; CELL PROLIFERATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG MECHANISM; G1 PHASE CELL CYCLE CHECKPOINT; HUMAN; HUMAN CELL; LUNG CANCER CELL LINE; MITOSIS INHIBITION; DRUG EFFECTS; GENE EXPRESSION PROFILING; LUNG TUMOR; METABOLISM; TUMOR CELL LINE;

ANTINEOPLASTIC AGENTS; APOPTOSIS; CELL LINE, TUMOR; G1 PHASE CELL CYCLE CHECKPOINTS; GENE EXPRESSION PROFILING; GLUTATHIONE; HUMANS; LUNG NEOPLASMS; ORGANOSELENIUM COMPOUNDS; SODIUM SELENITE;

EID: 84910055945     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.b14-00453     Document Type: Article

References (39)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J. Clin., 61, 69-90 (2011).
2. Pryor WA, Dooley MM, Church DF. Mechanisms of cigarette smoke toxicity: the inactivation of human alpha-1-proteinase inhibitor by nitric oxide/isoprene mixtures in air. Chem. Biol. Interact., 54, 171-183 (1985).
3. Valavanidis A, Vlachogianni T, Fiotakis K. Tobacco smoke: involvement of reactive oxygen species and stable free radicals in mechanisms of oxidative damage, carcinogenesis and synergistic effects with other respirable particles. Int. J. Environ. Res. Public Health, 6, 445-462 (2009).
4. Knaapen AM, Güngör N, Schins RP, Borm PJ, Van Schooten FJ. Neutrophils and respiratory tract DNA damage and mutagenesis: a review. Mutagenesis, 21, 225-236 (2006).
5. Tudek B, Swoboda M, Kowalczyk P, Oliński R. Modulation of oxidative DNA damage repair by the diet, inlammation and neoplastic transformation. J. Physiol. Pharmacol., 57 (Suppl. 7), 33-49 (2006).
6. Rayman MP. Selenium in cancer prevention: a review of the evidence and mechanism of action. Proc. Nutr. Soc., 64, 527-542 (2005).
7. Rayman MP, Infante HG, Sargent M. Food-chain selenium and human health: Spotlight on speciation. Br. J. Nutr., 100, 238-253 (2008).
8. Navarro Silvera SA, Rohan TE. Trace elements and cancer risk: a review of the epidemiologic evidence. Cancer Causes Control, 18, 7-27 (2007).
9. Nomura A, Heilbrun LK, Morris JS, Stemmermann GN. Serum selenium and the risk of cancer, by specific sites: case-control analysis of prospective data. J. Natl. Cancer Inst., 79, 103-108 (1987).
10. Zhuo H, Smith AH, Steinmaus C. Selenium and lung cancer: A quantitative analysis of heterogeneity in the current epidemiological literature. Cancer Epidemiol. Biomarkers Prev., 13, 771-778 (2004).
11. Ip C, Thompson HJ, Zhu Z, Ganther HE. In vitro and in vivo studies of methylseleninic acid: evidence that a monomethylated selenium metabolite is critical for cancer chemoprevention. Cancer Res., 60, 2882-2886 (2000).
12. Li GX, Lee HJ, Wang Z, Hu H, Liao JD, Watts JC, Combs GF Jr, Lü J. Superior in vivo inhibitory efficacy of methylseleninic acid against human prostate cancer over selenomethionine or selenite. Carcinogenesis, 29, 1005-1012 (2008).
13. Kryukov GV, Castellano S, Novoselov SV, Lobanov AV, Zehtab O, Guigo R, Gladyshev VN. Characterization of mammalian selenoproteomes. Science, 300, 1439-1443 (2003).
14. Gerald F. Combs Jr. Selenium as a cancer preventive agent. Selenium - its molecular biology and role in human health. (Hatfield DL, Berry MJ, Gladyshev VN eds.) 2nd Ed., Springer, New York, pp. 249-264 (2006).
15. Combs GF Jr, Gray WP. Chemopreventive agents: selenium. Pharmacol. Ther., 79, 179-192 (1998).
16. Ganther HE. Pathways of selenium metabolism including respiratory excretory product. J. Am. Coll. Toxicol., 5, 1-5 (1986).
17. Ohta Y, Suzuki KT. Methylation and demethylation of intermediates selenide and methylselenol in the metabolism of selenium. Toxicol. Appl. Pharmacol., 226, 169-177 (2008).
18. Sakazaki H, Ueno H, Umetani K, Utsumi H, Nakamuro K. Immunotoxicological evaluation of environmental chemicals utilizing mouse lymphocyte mitogenesis test. J. Health Sci., 47, 258-271 (2001).
19. Toyo'oka T, Imai K. High-performance liquid chromatography and luorometric detection of biologically important thiols, derivatized with ammonium 7-luorobenzo-2-oxa-1,3-diazole-4-sulphonate (SBD-F). J. Chromatogr., 282, 495-500 (1983).
20. Park SH, Kim JH, Chi GY, Kim GY, Chang YC, Moon SK, Nam SW, Kim WJ, Yoo YH, Choi YH. Induction of apoptosis and autophagy by sodium selenite in A549 human lung carcinoma cells through generation of reactive oxygen species. Toxicol. Lett., 212, 252-261 (2012).
21. Sinha R, Unni E, Ganther HE, Medina D. Methylseleninic acid, a potent growth inhibitor of synchronized mouse mammary epithelial tumor cells in vitro. Biochem. Pharmacol., 61, 311-317 (2001).
22. Dong Y, Ganther HE, Stewart C, Ip C. Identification of molecular targets associated with selenium-induced growth inhibition in human breast cells using cDNA microarrays. Cancer Res., 62, 708-714 (2002).
23. Homma S, Ishii Y, Morishima Y, Yamadori T, Matsuno Y, Haraguchi N, Kikuchi N, Satoh H, Sakamoto T, Hizawa N, Itoh K, Yamamoto M. Nrf2 enhances cell proliferation and resistance to anticancer drugs in human lung cancer. Clin. Cancer Res., 15, 3423-3432 (2009).
24. 1-phase progression. Genes Dev., 13, 1501-1512 (1999).
25. Boudreau RT, Conrad DM, Hoskin DW. Differential involvement of reactive oxygen species in apoptosis caused by the inhibition of protein phosphatase 2A in Jurkat and CCRF-CEM human T-leukemia cells. Exp. Mol. Pathol., 83, 347-356 (2007).
26. Jiang C, Wang Z, Ganther H, Lü J. Distinct effects of methylseleninic acid versus selenite on apoptosis, cell cycle, and protein kinase pathways in DU145 human prostate cancer cells. Mol. Cancer Ther., 1, 1059-1066 (2002).
27. Brozmanová J, Mániková D, Vlčkovà V, Chovanec M. Selenium: A double-edged sword for defense and offence in cancer. Arch. Toxicol., 84, 919-938 (2010).
28. Wang L, Bonorden MJ, Li GX, Lee HJ, Hu H, Zhang Y, Liao JD, Cleary MP, Lü J. Methyl-selenium compounds inhibit prostate carcinogenesis in the transgenic adenocarcinoma of mouse prostate model with survival benefit. Cancer Prev. Res. (Phila.), 2, 484-495 (2009).
29. 1 phase and apoptosis via the extra-cellular- regulated kinase 1/2 pathway and other cancer signaling genes. J. Nutr., 139, 1613-1618 (2009).
30. Wu G, Fang YZ, Yang S, Lupton JR, Turner ND. Glutathione metabolism and its implications for health. J. Nutr., 134, 489-492 (2004).
31. Lui C, Lui H, Li Y, Wu Z, Zhu Y, Wang T, Gao AC, Chen J, Zhou Q. Intracellular glutathione content inluences the sensitivity of lung cancer cell line to methylseleninic acid. Mol. Carcinog., 51, 303-314 (2012).
32. Drake EN. Cancer chemoprevention: selenium as a prooxidant, not an antioxidant. Med. Hypotheses, 67, 318-322 (2006).
33. Rikiishi H. Apoptotic cellular events for selenium compounds involved in cancer prevention. J. Bioenerg. Biomembr., 39, 91-98 (2007).
34. Johnson TM, Yu ZX, Ferrans VJ, Lowenstein RA, Finkel T. Reactive oxygen species are downstream mediators of p53-dependent apoptosis. Proc. Natl. Acad. Sci. U.S.A., 93, 11848-11852 (1996).
35. Polyak K, Xia Y, Zweier JL, Kinzler KW, Vogelstein B. A model for p53-induced apoptosis. Nature, 389, 300-305 (1997).
36. Macip S, Igarashi M, Berggren P, Yu J, Lee SW, Aaronson SA. Inluence of induced reactive oxygen species in p53-mediated cell fate decisions. Mol. Cell. Biol., 23, 8576-8585 (2003).
37. Jiang C, Hu H, Malewicz B, Wang Z, Lü J. Selenite-induced p53 Ser-15 phosphorylation and caspase-mediated apoptosis in LNCaP human prostate cancer cells. Mol. Cancer Ther., 3, 877-884 (2004).
38. Hu H, Jiang C, Li G, Lü J. PKB/AKT and ERK regulation of caspase-mediated apoptosis by methylseleninic acid in LNCaP prostate cancer cells. Carcinogenesis, 26, 1374-1381 (2005).
39. Jiang C, Wang Z, Ganther H, Lu J. Caspases as key executors of methyl selenium-induced apoptosis (anoikis) of DU-145 prostate cancer cells. Cancer Res., 61, 3062-3070 (2001).